nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCC2—bile canaliculus—sclerosing cholangitis	0.372	0.411	CbGeAlD
Lovastatin—ABCC2—bile duct—sclerosing cholangitis	0.116	0.128	CbGeAlD
Lovastatin—ABCC2—bile—sclerosing cholangitis	0.0893	0.0986	CbGeAlD
Lovastatin—PON3—pancreas—sclerosing cholangitis	0.0428	0.0472	CbGeAlD
Lovastatin—HMGCR—gall bladder—sclerosing cholangitis	0.0341	0.0377	CbGeAlD
Lovastatin—ITGAL—liver—sclerosing cholangitis	0.0277	0.0306	CbGeAlD
Lovastatin—PON3—liver—sclerosing cholangitis	0.0272	0.03	CbGeAlD
Lovastatin—UGT1A3—liver—sclerosing cholangitis	0.0236	0.026	CbGeAlD
Lovastatin—HDAC2—pancreas—sclerosing cholangitis	0.0174	0.0192	CbGeAlD
Lovastatin—HMGCR—pancreas—sclerosing cholangitis	0.0157	0.0174	CbGeAlD
Lovastatin—CYP3A7—liver—sclerosing cholangitis	0.014	0.0154	CbGeAlD
Lovastatin—UGT2B7—liver—sclerosing cholangitis	0.0136	0.015	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—liver—sclerosing cholangitis	0.0119	0.0131	CbGeAlD
Lovastatin—UGT1A1—liver—sclerosing cholangitis	0.0115	0.0127	CbGeAlD
Lovastatin—HDAC2—liver—sclerosing cholangitis	0.0111	0.0122	CbGeAlD
Lovastatin—HMGCR—liver—sclerosing cholangitis	0.01	0.011	CbGeAlD
Lovastatin—SLCO1B1—liver—sclerosing cholangitis	0.00959	0.0106	CbGeAlD
Lovastatin—SLCO1A2—liver—sclerosing cholangitis	0.0078	0.00861	CbGeAlD
Lovastatin—CYP3A5—pancreas—sclerosing cholangitis	0.00773	0.00853	CbGeAlD
Lovastatin—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00737	0.0785	CbGpPWpGaD
Lovastatin—ABCC2—liver—sclerosing cholangitis	0.00727	0.00802	CbGeAlD
Lovastatin—CYP2C19—liver—sclerosing cholangitis	0.00625	0.00689	CbGeAlD
Lovastatin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00616	0.0657	CbGpPWpGaD
Lovastatin—CYP2C8—liver—sclerosing cholangitis	0.00545	0.00602	CbGeAlD
Lovastatin—CYP3A5—liver—sclerosing cholangitis	0.00492	0.00543	CbGeAlD
Lovastatin—CYP2C9—liver—sclerosing cholangitis	0.00484	0.00534	CbGeAlD
Lovastatin—HMGCR—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00438	0.0467	CbGpPWpGaD
Lovastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00429	0.0457	CbGpPWpGaD
Lovastatin—ABCB1—pancreas—sclerosing cholangitis	0.00411	0.00453	CbGeAlD
Lovastatin—CYP3A4—liver—sclerosing cholangitis	0.00369	0.00407	CbGeAlD
Lovastatin—CYP2D6—liver—sclerosing cholangitis	0.00363	0.00401	CbGeAlD
Lovastatin—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00346	0.0369	CbGpPWpGaD
Lovastatin—HDAC2—p75 NTR receptor-mediated signalling—BCL2L11—sclerosing cholangitis	0.00297	0.0317	CbGpPWpGaD
Lovastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00296	0.0315	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—sclerosing cholangitis	0.00291	0.0311	CbGpPWpGaD
Lovastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0029	0.0309	CbGpPWpGaD
Lovastatin—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00284	0.0303	CbGpPWpGaD
Lovastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00271	0.0289	CbGpPWpGaD
Lovastatin—ABCB1—liver—sclerosing cholangitis	0.00261	0.00288	CbGeAlD
Lovastatin—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00251	0.0267	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—TCF4—sclerosing cholangitis	0.00242	0.0258	CbGpPWpGaD
Lovastatin—HDAC2—NOTCH1 Intracellular Domain Regulates Transcription—HIF1A—sclerosing cholangitis	0.00197	0.021	CbGpPWpGaD
Lovastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00179	0.019	CbGpPWpGaD
Lovastatin—UGT1A3—Phase II conjugation—GGT1—sclerosing cholangitis	0.00175	0.0187	CbGpPWpGaD
Lovastatin—HDAC2—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.0016	0.0171	CbGpPWpGaD
Lovastatin—UGT2B7—Phase II conjugation—GGT1—sclerosing cholangitis	0.00149	0.0159	CbGpPWpGaD
Lovastatin—HDAC2—FBXW7 Mutants and NOTCH1 in Cancer—HIF1A—sclerosing cholangitis	0.00142	0.0151	CbGpPWpGaD
Lovastatin—UGT1A1—Phase II conjugation—GGT1—sclerosing cholangitis	0.00121	0.0129	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00118	0.0125	CbGpPWpGaD
Lovastatin—UGT1A3—NRF2 pathway—GGT1—sclerosing cholangitis	0.00117	0.0125	CbGpPWpGaD
Lovastatin—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00117	0.0124	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00109	0.0117	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—GGT1—sclerosing cholangitis	0.00103	0.0109	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—HIF1A—sclerosing cholangitis	0.00101	0.0107	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.001	0.0107	CbGpPWpGaD
Lovastatin—UGT2B7—NRF2 pathway—GGT1—sclerosing cholangitis	0.000994	0.0106	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000894	0.00953	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—NOS2—sclerosing cholangitis	0.000873	0.0093	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—GGT1—sclerosing cholangitis	0.000872	0.00929	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000845	0.00901	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.000816	0.00869	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.000807	0.00861	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	0.000788	0.0084	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.000775	0.00826	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00077	0.0082	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000723	0.0077	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000711	0.00757	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.000708	0.00755	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000608	0.00648	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—GGT1—sclerosing cholangitis	0.000596	0.00635	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.000562	0.00599	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ABCB4—sclerosing cholangitis	0.000524	0.00559	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.000486	0.00518	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000483	0.00515	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000442	0.00472	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.000431	0.00459	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ABCB4—sclerosing cholangitis	0.000427	0.00456	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—GGT1—sclerosing cholangitis	0.000373	0.00397	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ABCB4—sclerosing cholangitis	0.000363	0.00387	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000362	0.00386	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000349	0.00372	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.000333	0.00355	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000316	0.00337	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000312	0.00332	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000306	0.00326	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000304	0.00324	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ABCB4—sclerosing cholangitis	0.000295	0.00315	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000291	0.00311	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000284	0.00303	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCB4—sclerosing cholangitis	0.000271	0.00288	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS2—sclerosing cholangitis	0.000268	0.00286	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000249	0.00266	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GOT2—sclerosing cholangitis	0.000249	0.00266	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCB4—sclerosing cholangitis	0.000248	0.00265	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GOT2—sclerosing cholangitis	0.000238	0.00253	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000235	0.00251	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GOT1—sclerosing cholangitis	0.000215	0.00229	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GGT1—sclerosing cholangitis	0.000215	0.00229	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GOT1—sclerosing cholangitis	0.000205	0.00219	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GOT2—sclerosing cholangitis	0.000203	0.00216	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.0002	0.00213	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.00018	0.00191	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GGT1—sclerosing cholangitis	0.000175	0.00187	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GOT1—sclerosing cholangitis	0.000175	0.00187	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GOT2—sclerosing cholangitis	0.000173	0.00184	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB4—sclerosing cholangitis	0.000156	0.00166	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GOT2—sclerosing cholangitis	0.00015	0.0016	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GGT1—sclerosing cholangitis	0.000149	0.00159	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GOT1—sclerosing cholangitis	0.000149	0.00159	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000143	0.00153	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HIF1A—sclerosing cholangitis	0.000143	0.00152	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GOT2—sclerosing cholangitis	0.00014	0.0015	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.000139	0.00148	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000135	0.00144	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS2—sclerosing cholangitis	0.00013	0.00138	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GGT1—sclerosing cholangitis	0.00013	0.00138	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GOT1—sclerosing cholangitis	0.00013	0.00138	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GOT2—sclerosing cholangitis	0.000129	0.00137	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000128	0.00136	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000128	0.00136	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.000127	0.00135	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GOT1—sclerosing cholangitis	0.000121	0.00129	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GGT1—sclerosing cholangitis	0.000121	0.00129	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GOT2—sclerosing cholangitis	0.000118	0.00126	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000117	0.00124	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GGT1—sclerosing cholangitis	0.000111	0.00118	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GOT1—sclerosing cholangitis	0.000111	0.00118	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GOT1—sclerosing cholangitis	0.000102	0.00109	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GGT1—sclerosing cholangitis	0.000102	0.00109	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.0001	0.00107	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	8.53e-05	0.000909	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	8.35e-05	0.00089	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GOT2—sclerosing cholangitis	7.39e-05	0.000787	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	7.36e-05	0.000785	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	7.36e-05	0.000785	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	6.59e-05	0.000703	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GOT2—sclerosing cholangitis	6.44e-05	0.000686	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GGT1—sclerosing cholangitis	6.38e-05	0.00068	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GOT1—sclerosing cholangitis	6.38e-05	0.00068	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	6.07e-05	0.000647	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	6.01e-05	0.000641	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	5.69e-05	0.000607	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	5.69e-05	0.000607	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GOT1—sclerosing cholangitis	5.56e-05	0.000592	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GGT1—sclerosing cholangitis	5.56e-05	0.000592	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	5.24e-05	0.000558	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	5.24e-05	0.000558	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	5.19e-05	0.000553	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	5.19e-05	0.000553	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	3.97e-05	0.000423	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	3.42e-05	0.000365	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	3.42e-05	0.000365	CbGpPWpGaD
